跳至主要内容
临床试验/NCT00238862
NCT00238862已完成不适用

Efficacy of Amniotic Membrane Transplantation and Autologous Serum in Treatment of Persistent Epithelial Defects

King Khaled Eye Specialist Hospital2 个研究点 分布在 1 个国家目标入组 180 人开始时间: 2005年10月最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
180
试验地点
2
主要终点
Corneal re-epithelialization (= initial success)

研究概览

简要总结

Patients with persistent corneal epithelial defects who have not responded to conventional therapy will be randomized to treatment with either amniotic membrane transplantation or autologous serum 20%. Outcome measures will be (1) presence or absence of complete re-epithelialization within 28 days and (2) retention of intact epithelium for at least 90 days.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Corneal epithelial defect of more than 14 days that has not responded to conventional therapy

排除标准

  • Under age 18
  • Pregnant/lactating females
  • Patients with hemoglobin levels < 12 mg/ml
  • Patients with limbal stem cell deficiency

结局指标

主要结局

Corneal re-epithelialization (= initial success)

Persistent corneal re-epithelialization (= lasting success)

次要结局

未报告次要终点

研究者

申办方类型
Other Gov
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验